Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Non-Current Debt (2019 - 2021)

Historic Non-Current Debt for International Stem Cell (ISCO) over the last 3 years, with Q2 2021 value amounting to $476000.0.

  • International Stem Cell's Non-Current Debt changed N/A to $476000.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $476000.0, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2020, which is 443.04% up from last year.
  • International Stem Cell's Non-Current Debt amounted to $476000.0 in Q2 2021.
  • In the past 5 years, International Stem Cell's Non-Current Debt registered a high of $2.5 million during Q4 2020, and its lowest value of $476000.0 during Q2 2021.
  • For the 3-year period, International Stem Cell's Non-Current Debt averaged around $1.4 million, with its median value being $915000.0 (2021).
  • Examining YoY changes over the last 5 years, International Stem Cell's Non-Current Debt showed a top increase of 443.04% in 2020 and a maximum decrease of 443.04% in 2020.
  • Over the past 3 years, International Stem Cell's Non-Current Debt (Quarter) stood at $2.4 million in 2019, then increased by 4.43% to $2.5 million in 2020, then tumbled by 80.77% to $476000.0 in 2021.
  • Its Non-Current Debt was $476000.0 in Q2 2021, compared to $915000.0 in Q1 2021 and $2.5 million in Q4 2020.